31 related articles for article (PubMed ID: 16969277)
1. Overlap between genetic variants associated with schizophrenia spectrum disorders and intelligence quotient: a systematic review.
Murillo-García N; Barrio-Martínez S; Setién-Suero E; Soler J; Papiol S; Fatjó-Vilas M; Ayesa-Arriola R
J Psychiatry Neurosci; 2022; 47(6):E393-E408. PubMed ID: 36414327
[TBL] [Abstract][Full Text] [Related]
2. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review.
Schacht JP
Pharmacogenomics J; 2016 Oct; 16(5):430-8. PubMed ID: 27241058
[TBL] [Abstract][Full Text] [Related]
3. Brain plasticity and genetic factors.
Pearson-Fuhrhop KM; Kleim JA; Cramer SC
Top Stroke Rehabil; 2009; 16(4):282-99. PubMed ID: 19740733
[TBL] [Abstract][Full Text] [Related]
4. COMT Val158Met and cognition: main effects and interaction with educational attainment.
Enoch MA; Waheed JF; Harris CR; Albaugh B; Goldman D
Genes Brain Behav; 2009 Feb; 8(1):36-42. PubMed ID: 19076243
[TBL] [Abstract][Full Text] [Related]
5. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum.
Yavich L; Forsberg MM; Karayiorgou M; Gogos JA; Männistö PT
J Neurosci; 2007 Sep; 27(38):10196-209. PubMed ID: 17881525
[TBL] [Abstract][Full Text] [Related]
6. Cognitive heterogeneity in schizophrenia.
Joyce EM; Roiser JP
Curr Opin Psychiatry; 2007 May; 20(3):268-72. PubMed ID: 17415081
[TBL] [Abstract][Full Text] [Related]
7. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.
Jann MW
Pharmacotherapy; 2004 Dec; 24(12):1759-83. PubMed ID: 15585443
[TBL] [Abstract][Full Text] [Related]
8. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
Lewandowski KE
Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
[TBL] [Abstract][Full Text] [Related]
9. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
[TBL] [Abstract][Full Text] [Related]
11. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
[TBL] [Abstract][Full Text] [Related]
12. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
[TBL] [Abstract][Full Text] [Related]
13. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
[TBL] [Abstract][Full Text] [Related]
14. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis.
Mata I; Arranz MJ; Staddon S; Lopez-Ilundain JM; Tabares-Seisdedos R; Murray RM
Psychiatr Genet; 2006 Oct; 16(5):213-6. PubMed ID: 16969277
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
